Avoro Capital Advisors LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$7.1T
Holdings
39
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (39 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | UTHUNITED THERAPEUTICS CORP | 2,760,300 | $973.9B | 13.78% | |
| 2 | ARGXARGENX SE | 1,238,467 | $761.7B | 10.77% | |
| 3 | ASNDASCENDIS PHARMA | 5,103,055 | $702.5B | 9.94% | |
| 4 | MDGLMADRIGAL PHARMACEUTICALS INC | 2,029,000 | $626.1B | 8.86% | |
| 5 | KRYSKRYSTAL BIOTECH INC | 2,628,822 | $411.8B | 5.83% | |
| 6 | APLSAPELLIS PHARMACEUTICALS INC. | 12,222,222 | $390.0B | 5.52% | |
| 7 | SRPTSAREPTA THERAPEUTICS INC | 2,555,555 | $310.7B | 4.40% | |
| 8 | ITCIEURINTRA-CELLULAR THERAPIES INC | 3,050,000 | $254.7B | 3.60% | |
| 9 | VERAVERA THERAPEUTICS INC | 5,610,000 | $237.2B | 3.36% | |
| 10 | XENEXENON PHARMACEUTICALS INC | 5,666,666 | $222.1B | 3.14% | |
| 11 | AM6AMICUS THERAPEUTICS INC. | 23,175,000 | $218.3B | 3.09% | |
| 12 | RNAAVIDITY BIOSCIENCES INC | 7,500,000 | $218.1B | 3.08% | |
| 13 | ARWRARROWHEAD PHARMACEUTICALS INC. | 11,111,111 | $208.9B | 2.95% | |
| 14 | KYMRKYMERA THERAPEUTICS INC | 5,150,000 | $207.2B | 2.93% | |
| 15 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 2,770,100 | $150.0B | 2.12% | |
| 16 | SLNOSOLENO THERAPEUTICS INC | 2,525,000 | $113.5B | 1.61% | |
| 17 | 2L9BLUEPRINT MEDICINES CORP | 1,185,000 | $103.4B | 1.46% | |
| 18 | PCVXVAXCYTE INC | 1,175,000 | $96.2B | 1.36% | |
| 19 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,462,500 | $96.1B | 1.36% | |
| 20 | MRUSMERUS N V | 2,125,000 | $89.4B | 1.26% | |
| 21 | BCRXBIOCRYST PHARMACEUTICALS INC | 11,865,000 | $89.2B | 1.26% | |
| 22 | ALKSALKERMES PLC | 2,450,000 | $70.5B | 1.00% | |
| 23 | OCULOCULAR THERAPEUTIX INC | 8,060,000 | $68.8B | 0.97% | |
| 24 | MNKDMANNKIND CORP | 8,750,000 | $56.3B | 0.80% | |
| 25 | TRMLTOURMALINE BIO INC | 2,222,222 | $45.1B | 0.64% | |
| 26 | QUREUNIQURE NV | 2,175,000 | $38.4B | 0.54% | |
| 27 | RAREULTRAGENYX PHARMACEUTICAL INC | 830,000 | $34.9B | 0.49% | |
| 28 | TSHATAYSHA GENE THERAPIES INC | 19,999,999 | $34.6B | 0.49% | |
| 29 | ETNBGBP89BIO INC | 4,100,000 | $32.1B | 0.45% | |
| 30 | GLUEMONTE ROSA THERAPEUTICS INC | 4,345,000 | $30.2B | 0.43% | |
| 31 | SNDXSYNDAX PHARMACEUTICALS INC | 2,275,000 | $30.1B | 0.43% | |
| 32 | IOVAIOVANCE BIOTHERAPEUTICS INC | 3,500,000 | $25.9B | 0.37% | |
| 33 | SEPNSEPTERNA INC | 1,110,000 | $25.4B | 0.36% | |
| 34 | AUTLAUTOLUS THERAPEUTICS PLC | 9,910,642 | $23.3B | 0.33% | |
| 35 | CGONCG ONCOLOGY INC | 700,000 | $20.1B | 0.28% | |
| 36 | KURAKURA ONCOLOGY INC | 2,250,000 | $19.6B | 0.28% | |
| 37 | RCKTROCKET PHARMACEUTICALS INC | 1,200,000 | $15.1B | 0.21% | |
| 38 | OLMAOLEMA PHARMACEUTICALS INC | 1,651,982 | $9.6B | 0.14% | |
| 39 | WHWKAADI BIOSCIENCES INC | 2,849,402 | $9.0B | 0.13% |